Frontlight ResearchEarly access
Retinitis pigmentosa trials in United States
13 of 27 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome
- Where
- Dallas
- Age
- 18 years and over
- People
- 80
- Run by
- Nacuity Pharmaceuticals, Inc.
See details and how to joinNCT07710196 - Phase 2/3Taking peopleStudy to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT)
- Where
- ‘Aiea, Bakersfield, Beverly Hills, Bloomfield, Deerfield Beach, Detroit, Edina, Greensboro, Mt. Pleasant, Oak Park, Phoenix, Portland, San Antonio, Santa Barbara
- Age
- 18 years and over
- People
- 60
- Run by
- Ray Therapeutics, Inc.
See details and how to joinNCT07901751 - Phase 1Taking peopleSafety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION
- Where
- Naples
- People
- 20 worldwide
- Run by
- The Foundation for Orthopaedics and Regenerative Medicine
See details and how to joinNCT05147701 - Phase 1/2Taking peopleA Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
- Where
- Dallas, Los Angeles, Madison, Miami, Philadelphia
- Age
- 18 years and over
- People
- 54
- Run by
- BlueRock Therapeutics
See details and how to joinNCT06789445 - Phase 1/2Taking peopleA Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
- Where
- Dallas, Portland
- Age
- 18 years and over
- People
- 18
- Run by
- Octant, Inc.
See details and how to joinNCT07408232 - Phase 1Taking peopleThe Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
- Where
- Rochester
- Age
- 18 years and over
- People
- 15
- Run by
- University of Rochester
See details and how to joinNCT06319872 - No phaseTaking peopleStem Cell Ophthalmology Treatment Study II
- Where
- Coral Springs, Westport
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- MD Stem Cells
See details and how to joinNCT03011541 - Early phase 1Enrolling by invitationAntisense Oligonucleotide Treatment for PCARP Disease Due to Mutation in FLVCR1
- Where
- Aurora
- People
- 1
- Run by
- University of Colorado, Denver
See details and how to joinNCT06565572 - Phase 1/2Taking peopleDisulfiram for Treatment of Retinal Degeneration
- Where
- Seattle
- Age
- 18 years and over
- People
- 30
- Run by
- University of Washington
See details and how to joinNCT05626920 - Phase 1/2Taking peopleA Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
- Where
- Boston, Minneapolis
- Age
- 18 years and over
- People
- 12
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT06891885 - Phase 1/2Taking peopleBS01 in Patients With Retinitis Pigmentosa
- Where
- Teaneck
- Age
- 18 years and over
- People
- 20
- Run by
- Bionic Sight LLC
See details and how to joinNCT04278131 - Phase 2Enrolling by invitationA Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN)
- Where
- Boston, Cincinnati, Cleveland, Dallas, Jacksonville, Miami, Portland
- Age
- 12 years and over
- People
- 24
- Run by
- Beacon Therapeutics
See details and how to joinNCT06275620 - No phaseTaking peopleExperimental and Clinical Studies of Retinal Stimulation
- Where
- Ann Arbor
- Age
- 25 years to 89 years
- People
- 20
- Run by
- University of Michigan
See details and how to joinNCT03635645